Atrioventricular optimization in cardiac resynchronization therapy with quadripolarleads, improves energy handling and quality of life in heart failure patients: HUMVEE Trial

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Christos-Konstantinos Antoniou

Athens Medical Centre, Athens (Greece)

8 More presentations in this session

Presentation thumbnail

His bundle pacing in patients pacemaker indication and with mildly reduced ejection fraction

Mr R. Gardas (Katowice, PL)

Abstract Slides

Presentation thumbnail

Differential effect of CRT in ischemic and non-ischemic cardiomyopathy: longterm follow-up data from a single center cohort study

Doctor P. Kahr (Schlieren, CH)

Presentation thumbnail

Implant procedure and lead handling characteristics of a novel active fixation quadripolar lead: Results from the Attain Stability Quad clinical trial

Professor S. Faerestrand (Bergen, NO)

Abstract Slides

Presentation thumbnail

Cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy and severe heart failure may influence the development of unstable ventricular tachycardia

Doctor D. Lebedev (Kemerovo, RU)

Presentation thumbnail

Are there shock incidence and mortality differences in primary prevention patients regarding device type and ischemia? A NORDIC ICD sub-study.

Professor H. Bonnemeier (Luebeck, DE)

Access the full session

Session thumbnail

Poster Session 5 - Heart failure devices: new approaches

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Cardiac resynchronisation therapy

Congress Session

Navigating through heart failure device therapies

Congress Presentation

Conduction system pacing in the current treatment of HFrEF patients

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources